Guide — Renal
Bladder Cancer Nursing Care
The classic teaching point is one symptom: painless gross hematuria in a smoker is bladder cancer until proven otherwise. Nursing care spans that recognition through intravesical therapy and urinary diversion.
9 min read · Renal
Educational use only. Diagnosis, staging, and treatment selection are provider-directed and individualized. This guide is educational background for nursing care. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
Overview
Most bladder cancers are urothelial (transitional cell) carcinoma. The majority present as non-muscle-invasive disease, which is treated with bladder-sparing resection and intravesical therapy but has a high recurrence rate (so lifelong surveillance is needed). Muscle-invasive disease requires more aggressive treatment, often radical cystectomy with urinary diversion. The strongest modifiable risk factor is smoking; occupational exposure to aromatic amines (dyes, rubber, chemicals) also raises risk.
Key Concepts
Presentation
The hallmark is painless gross (visible) hematuria, often intermittent. There may be irritative voiding symptoms (frequency, urgency, dysuria) that mimic a UTI. Painless hematuria should never be dismissed (see the hematuria chart).
Diagnosis & staging
Cystoscopy with biopsy is definitive; urine cytology and imaging help. Staging follows the TNM system; the key division is non-muscle-invasive vs muscle-invasive.
TURBT & intravesical therapy
Non-muscle-invasive tumors are removed by transurethral resection of bladder tumor (TURBT), often followed by intravesical BCG (immunotherapy instilled into the bladder) or chemotherapy to reduce recurrence. BCG requires special handling.
Cystectomy & urinary diversion
Muscle-invasive disease may require radical cystectomy with a urinary diversion: an ileal conduit (incontinent urostomy with a stoma and pouch), a continent cutaneous reservoir, or an orthotopic neobladder (see the urinary diversion & stoma reference).
Assessment Findings
Ask about visible blood in the urine (painless, intermittent), irritative voiding symptoms, smoking and occupational history. After TURBT, monitor for hematuria, clots, and continuous bladder irrigation patency. With a new urostomy, assess the stoma (should be pink/red and moist), urine output, and peristomal skin. Mucus in the urine is normal with bowel-segment diversions.
Nursing Priorities
Post-TURBT care
Monitor urine for bleeding and clots, maintain continuous bladder irrigation patency (keep output flowing; titrate irrigation to keep urine light pink), manage bladder spasms, and encourage fluids. Report bright-red bleeding or clot retention.
Intravesical BCG handling
BCG is a live attenuated agent: follow safe handling, have the patient retain it as ordered, then for several hours after voiding disinfect the toilet (e.g., add bleach) and practice careful hand hygiene. Watch for cystitis-like symptoms and, rarely, systemic BCG infection (fever).
Urostomy/diversion care
Assess stoma viability (pink/red, moist; report dusky/dark), protect peristomal skin, fit the appliance, ensure continuous urine drainage, and teach self-care with a WOC nurse. Expect and explain mucus in the urine.
Smoking cessation & surveillance
Support smoking cessation and reinforce the need for lifelong surveillance cystoscopy given the high recurrence rate.
Therapeutic Communication Considerations
A urostomy profoundly affects body image and sexuality. Be matter-of-fact and supportive, protect privacy and dignity, and normalize concerns about appliances, odor, leakage, and intimacy. Involve a WOC nurse and ostomy support groups early. Offer smoking-cessation support without blame, and address the anxiety of recurrence with honest information and a clear surveillance plan.
Patient & Family Education
Stress reporting any blood in the urine and adhering to surveillance cystoscopy (recurrence is common). For BCG, teach post-instillation toilet precautions. Teach thorough urostomy self-care (appliance, skin, signs of stoma problems, normal mucus), adequate hydration, and signs of UTI. Emphasize smoking cessation as the most important modifiable factor.
NCLEX Pearls
- ✦Painless gross hematuria (esp. in a smoker) = bladder cancer until proven otherwise — never dismiss it.
- ✦Smoking is the #1 modifiable risk factor; aromatic-amine occupational exposure also raises risk.
- ✦Non-muscle-invasive tumors: TURBT + intravesical BCG; recurrence is common → lifelong surveillance cystoscopy.
- ✦After intravesical BCG, disinfect the toilet (bleach) for several hours after voiding — it's a live agent.
- ✦After TURBT, monitor for hematuria/clots and keep continuous bladder irrigation flowing.
- ✦Ileal-conduit urostomy: a healthy stoma is pink/red and moist; mucus in the urine is NORMAL.
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with KDIGO Clinical Practice Guidelines · National Kidney Foundation (NKF). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →